Effect of one-time dextran-polyacrylamide polymer matrixes treatment on female reproductive function

Background: recently, it has been proved that copolymers with dextran cores and grafted polyacrylamide are effective in photodynamic and chemotherapy. However, further research is needed to define correct dosage and to assess the risks. Thus, animal studies are becoming more relevant to determine the effect of the treatment of such drug nano-systems on female reproductive function in particular.Methods: a technique for estimation of pre- and post-implantation death rates, in vitro meotic maturation of oocytes, double fluorescent vital assay and statistical analysis were used. The effects of a one-time treatment of different doses of dextran-polyacrylamide matrices and silver (Ag)-nanoparticles-dextran-polyacrylamide (AgNPs-D-PAA) on reproductive function, namely on 1) the number of oocytes isolated from one ovary and the meiotic maturation of such oocytes in vitro; 2) the indicators of cell viability of the cells of follicular environment of oocytes (FEO) and the cells of inguinal lymph nodes (ILN); 3) the pre- and post-implantation mortality rates and the number of live newborns (pups) were investigated in female mice.Results: no significant changes in the number of oocytes isolated from one ovary and meiotic maturation of such ovarian oocytes in vitro, the number of living cells of follicular environment of oocytes  and the number of such cells with morphological signs of apoptosis and necrosis, pre- and post-implantation mortality rates of embryos and the number of live newborns (pups) have been established under conditions of one-time treatment with dextran-polyacrylamide at doses of 0.39 mg/kg and 3.90 mg/kg and Ag-nanoparticles-dextran-polyacrylamide at doses of 0.20 mg/kg and 2.00 mg/kg.Conclusions: branched polymer systems (dextran-polyacrylamide (D-PAA) polymer matrices) are promising materials for use in next-generation medicine

Effect of gold nanocomposites treatment on male reproductive function under conditions of experimental hyperglycemia

Background: Given the urgency of the problem of clinical and experimental pathology of diabetes mellitus (DM) and the reproductive function disorders and their correction, the direction of research was determined in the following way: to establish the functional state of testicular cells and appendages under experimental hyperglycemia, and to assess future prospects for gold nanoparticles for clinical trials. The aims to evaluate the effect of five times treatment with gold nanocomposites (gold nanoparticles (AuNPs) in the polymer matrix D-g-PAA(PE) on male reproductive function under conditions of experimental hyperglycemia.Methods: Experiments (two series) have been conducted on 120 (60 males and 60 females) Albino white laboratory mice (weighing 25-30 gm). Experimental hyperglycemia, a model of type 2 diabetes mellitus (DM2) was reproduced by administration of nicotinamide and streptozotocin (internally peritoneally). The treatment of substances was carried out in the following way: D-g-PAA (PE) (10.00 mg/kg), D-g-PAA (PE)/AuNPs (9.78 mg/kg) in the tail vein, in 0.3 ml, once a day, five times, 2 weeks after EG induction once a day, five times.Results: it was established for the first time that there is disorder of male reproductive function under conditions of experimental hyperglycemia and five-fold treatment of gold nanocomposites (D-g-PAA(PE)/AuNPs, namely an increase in the number of abnormal sperm and a decrease in spermatids, as well as an increase in preimplantation mortality of embryos (compared to this value under experimental hyperglycemia).Conclusions: Our new data suggest that treatment with such gold nanocomposites (gold nanoparticles in D-g-PAA (PE) polymer matrix) are not critical for therapeutic use (in photodynamic chemotherapy), even in hyperglycemia when there is diabetes